10Z-Hymenialdisine
CAS: 82005-12-7
Ref. 3D-HDA00512
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Informação sobre produto
- (4E)-4-(2-amino-5-oxo-1,5-dihydro-4H-imidazol-4-ylidene)-2-bromo-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8(1H)-one
- (4Z)-4-(2-Amino-1,5-dihydro-5-oxo-4H-imidazol-4-ylidene)-2-bromo-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8(1H)-one
- (Z)-Hymenialdisine
- Hymenialdesine
- Hymenialdisine
- Pyrrolo[2,3-c]azepin-8(1H)-one, 4-(2-amino-1,5-dihydro-5-oxo-4H-imidazol-4-ylidene)-2-bromo-4,5,6,7-tetrahydro-, (4Z)-
- Pyrrolo[2,3-c]azepin-8(1H)-one, 4-(2-amino-1,5-dihydro-5-oxo-4H-imidazol-4-ylidene)-2-bromo-4,5,6,7-tetrahydro-, (Z)-
- pyrrolo[2,3-c]azepin-8(1H)-one, 4-(2-amino-1,5-dihydro-5-oxo-4H-imidazol-4-ylidene)-2-bromo-4,5,6,7-tetrahydro-, (4E)-
Hymenialdisine is a novel inhibitor of kinases that has been shown to be effective against cancer cells and hepatocyte-like cells. It has been found to inhibit the activity of a number of kinases, including Epidermal Growth Factor Receptor (EGFR), c-Src, and p38 mitogen-activated protein kinase (MAPK). The molecular docking analysis revealed that hymenialdisine can bind within the ATP binding pocket of these kinases. Hymenialdisine also showed biological properties in a sponge model system as well as in marine organisms such as sponges and sea anemones.
Propriedades químicas
Consulta técnica sobre: 3D-HDA00512 10Z-Hymenialdisine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.